Using streptozotocin (STZ)-induced diabetic ApoE−/− mice, we found that metformin reduces atherosclerotic plaques, while S177A-Pdlim5, an unphosphorylatable mutant that carried adenovirus, undermines metformin's anti-atherosclerosis function. The gene discussed is PDLIM5; the disease is atherosclerosis.